{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6388909dcb17a60010c40c56/65e97c241428cc0016896771?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Lytix Biopharma – Innovations in Killing Cancer","description":"<p>Following recent encouraging interim clinical results, hear Øystein Rekdal, CEO of Lytix Biopharma, discuss with Optimum's Nick Bastin how the company's lead candidate LTX-315 has a unique approach to killing cancer. </p>","author_name":"Optimum Strategic Communications"}